Bristol Myers Squibb get EC approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with…
Opdivo plus Yervoy-based combinations now indicated in the EU for three different advanced cancer types: non-small cell lung…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Yervoy
CHMP advises approval for Bristol Myers Squibb’s Opdivo plus Yervoy with chemo for metastatic NSCLC
The European Commission will now review the CHMP recommendation